Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

High absorption but very low bioavailability of oral resveratrol in humans.

Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK.

Drug Metab Dispos. 2004 Dec;32(12):1377-82. Epub 2004 Aug 27.

2.

Metabolism and bioavailability of trans-resveratrol.

Wenzel E, Somoza V.

Mol Nutr Food Res. 2005 May;49(5):472-81. Review.

PMID:
15779070
3.

Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration.

Vitrac X, Desmoulière A, Brouillaud B, Krisa S, Deffieux G, Barthe N, Rosenbaum J, Mérillon JM.

Life Sci. 2003 Apr 4;72(20):2219-33.

PMID:
12628442
4.

Bioavailability of trans-resveratrol from red wine in humans.

Vitaglione P, Sforza S, Galaverna G, Ghidini C, Caporaso N, Vescovi PP, Fogliano V, Marchelli R.

Mol Nutr Food Res. 2005 May;49(5):495-504.

PMID:
15830336
5.

Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats.

Kapetanovic IM, Muzzio M, Huang Z, Thompson TN, McCormick DL.

Cancer Chemother Pharmacol. 2011 Sep;68(3):593-601. doi: 10.1007/s00280-010-1525-4. Epub 2010 Nov 30.

6.

Bioavailability of resveratrol.

Walle T.

Ann N Y Acad Sci. 2011 Jan;1215:9-15. doi: 10.1111/j.1749-6632.2010.05842.x. Review.

PMID:
21261636
7.

Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model.

Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP, Ducharme MP.

J Pharmacol Exp Ther. 2002 Jul;302(1):369-73.

8.

The absorption, distribution, metabolism and excretion of Riccardin D in rats.

Ling X, Xing J, Zhang JZ, Chen WF, Zan X, Du FY, Li XX, Yao H, Lou HX.

Drug Res (Stuttg). 2013 Mar;63(3):159-64. doi: 10.1055/s-0033-1334895. Epub 2013 Feb 21.

PMID:
23430703
9.

Gut and microbial resveratrol metabolite profiling after moderate long-term consumption of red wine versus dealcoholized red wine in humans by an optimized ultra-high-pressure liquid chromatography tandem mass spectrometry method.

Rotches-Ribalta M, Urpi-Sarda M, Llorach R, Boto-Ordoñez M, Jauregui O, Chiva-Blanch G, Perez-Garcia L, Jaeger W, Guillen M, Corella D, Tinahones FJ, Estruch R, Andres-Lacueva C.

J Chromatogr A. 2012 Nov 23;1265:105-13. doi: 10.1016/j.chroma.2012.09.093. Epub 2012 Oct 1.

PMID:
23089514
10.

Resveratrol transport and metabolism by human intestinal Caco-2 cells.

Kaldas MI, Walle UK, Walle T.

J Pharm Pharmacol. 2003 Mar;55(3):307-12.

PMID:
12724035
11.

Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats.

Wenzel E, Soldo T, Erbersdobler H, Somoza V.

Mol Nutr Food Res. 2005 May;49(5):482-94.

PMID:
15779067
12.
13.

Inhibition of cancer growth by resveratrol is related to its low bioavailability.

Asensi M, Medina I, Ortega A, Carretero J, Baño MC, Obrador E, Estrela JM.

Free Radic Biol Med. 2002 Aug 1;33(3):387-98.

PMID:
12126761
14.
15.

Distribution of [3H]trans-resveratrol in rat tissues following oral administration.

Abd El-Mohsen M, Bayele H, Kuhnle G, Gibson G, Debnam E, Kaila Srai S, Rice-Evans C, Spencer JP.

Br J Nutr. 2006 Jul;96(1):62-70.

PMID:
16869992
16.

Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene.

Sale S, Verschoyle RD, Boocock D, Jones DJ, Wilsher N, Ruparelia KC, Potter GA, Farmer PB, Steward WP, Gescher AJ.

Br J Cancer. 2004 Feb 9;90(3):736-44.

17.

Assessment of resveratrol bioavailability in the perfused small intestine of the rat.

Andlauer W, Kolb J, Siebert K, Fürst P.

Drugs Exp Clin Res. 2000;26(2):47-55.

PMID:
10894555
18.

Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats.

Egorin MJ, Lagattuta TF, Hamburger DR, Covey JM, White KD, Musser SM, Eiseman JL.

Cancer Chemother Pharmacol. 2002 Jan;49(1):7-19.

PMID:
11855755
20.

Identification of metabolic pattern and bioactive form of resveratrol in human medulloblastoma cells.

Shu XH, Li H, Sun Z, Wu ML, Ma JX, Wang JM, Wang Q, Sun Y, Fu YS, Chen XY, Kong QY, Liu J.

Biochem Pharmacol. 2010 May 15;79(10):1516-25. doi: 10.1016/j.bcp.2010.01.022. Epub 2010 Jan 25.

PMID:
20105429

Supplemental Content

Support Center